The Center for Biomedical Research, Tongji Hospital Research Building, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Search for other papers by Chunliang Yang in
Google Scholar
PubMed
Search for other papers by Junyi Li in
Google Scholar
PubMed
Search for other papers by Fei Sun in
Google Scholar
PubMed
Search for other papers by Haifeng Zhou in
Google Scholar
PubMed
Search for other papers by Jia Yang in
Google Scholar
PubMed
Search for other papers by Chao Yang in
Google Scholar
PubMed
blood glucose fluctuation; however, it is unclear whether SGK1 is implicated and what role it plays in hyperglycemia-induced muscle wasting. Adipose tissue is deemed to be a key modulator of fuel metabolism and glucose homeostasis. Despite high salt
Search for other papers by Yuka Goto in
Google Scholar
PubMed
Search for other papers by Yoshie Otsuka in
Google Scholar
PubMed
Search for other papers by Kenji Ashida in
Google Scholar
PubMed
Search for other papers by Ayako Nagayama in
Google Scholar
PubMed
Search for other papers by Nao Hasuzawa in
Google Scholar
PubMed
Search for other papers by Shimpei Iwata in
Google Scholar
PubMed
Search for other papers by Kento Hara in
Google Scholar
PubMed
Search for other papers by Munehisa Tsuruta in
Google Scholar
PubMed
Search for other papers by Nobuhiko Wada in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Diabetes Center, Kurume Medical Center, Kokubu-machi, Kurume-city, Fukuoka, Japan
Search for other papers by Seiichi Motomura in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Diabetes Center, Kurume Medical Center, Kokubu-machi, Kurume-city, Fukuoka, Japan
Search for other papers by Yuji Tajiri in
Google Scholar
PubMed
Search for other papers by Masatoshi Nomura in
Google Scholar
PubMed
sensitivity were positively correlated with those in the rate of daily plasma glucose profile fluctuations. The duration of diabetes mellitus was not correlated with the improvement in insulin sensitivity through SGLT2 inhibitor administration. Collectively
Search for other papers by Dmitry M Davydov in
Google Scholar
PubMed
Search for other papers by Malik K Nurbekov in
Google Scholar
PubMed
Introduction Despite the known limitations of diagnostic criteria and early risk for type 2 diabetes derived from fasting (FPG) and/or 2-h plasma glucose levels, they are still widely accepted. Glycated hemoglobin A1 or the percentage of total
Search for other papers by Henry Zelada in
Google Scholar
PubMed
Search for other papers by M Citlalli Perez-Guzman in
Google Scholar
PubMed
Search for other papers by Daniel R Chernavvsky in
Google Scholar
PubMed
Search for other papers by Rodolfo J Galindo in
Google Scholar
PubMed
references is smaller in that range which can impact the MARD calculation ( 31 ). Moreover, patients in the ICU present unique challenges to glycemic control, with highly fluctuating glucose levels influenced by factors such as nutritional support, steroid
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Search for other papers by Reem A Emad in
Google Scholar
PubMed
Search for other papers by Martin H Lundqvist in
Google Scholar
PubMed
Search for other papers by Niclas Abrahamsson in
Google Scholar
PubMed
Search for other papers by Maria C Kjellsson in
Google Scholar
PubMed
responses to glucose fluctuations in individuals with insulin resistance, but their respective roles need further validation in large prospective cohorts. It was previously reported that elevated counter-regulatory neuroendocrine responses to hypoglycemia
Search for other papers by Po-Chung Cheng in
Google Scholar
PubMed
Search for other papers by Chia-Hung Kao in
Google Scholar
PubMed
Baynes HW . Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review . EJIFCC 2019 30 179 – 194 . 25 Zhang X Xu X Jiao X Wu J Zhou S Lv X . The effects of glucose fluctuation on the severity of
Search for other papers by Xiuzhen Zhang in
Google Scholar
PubMed
Search for other papers by Dan Xu in
Google Scholar
PubMed
Search for other papers by Ping Xu in
Google Scholar
PubMed
Search for other papers by Shufen Yang in
Google Scholar
PubMed
Search for other papers by Qingmei Zhang in
Google Scholar
PubMed
Search for other papers by Yan Wu in
Google Scholar
PubMed
Search for other papers by Fengyi Yuan in
Google Scholar
PubMed
complications than constant hyperglycemia ( 12 ). For this reason, novel approaches to flattening glucose fluctuations that will reduce the risk of CVD in T1DM are in dire need. For over five decades, metformin is an oral antihyperglycemic drug that has been
Search for other papers by Wei Liu in
Google Scholar
PubMed
Search for other papers by Yunke Ma in
Google Scholar
PubMed
Search for other papers by Xiaoling Cai in
Google Scholar
PubMed
Search for other papers by Yu Zhu in
Google Scholar
PubMed
Search for other papers by Mingxia Zhang in
Google Scholar
PubMed
Search for other papers by Juan Li in
Google Scholar
PubMed
Search for other papers by Jing Chen in
Google Scholar
PubMed
Search for other papers by Dawei Shi in
Google Scholar
PubMed
Search for other papers by Linong Ji in
Google Scholar
PubMed
serum C-peptide level was associated with higher TIR and less blood glucose fluctuation recorded by CGM in children and adolescents with type 1 diabetes less than 2 years, but not with hypoglycemia ( 14 ). In another study conducted on adult type 1
Search for other papers by Jared G Friedman in
Google Scholar
PubMed
Search for other papers by Kasey Coyne in
Google Scholar
PubMed
Search for other papers by Grazia Aleppo in
Google Scholar
PubMed
Search for other papers by Emily D Szmuilowicz in
Google Scholar
PubMed
simply described as the degree to which an individual’s blood glucose concentration fluctuates. The metric of %CV is calculated as ( s.d. of glucose/mean glucose) × 100 and encompasses the duration, frequency, and amplitude of shifts in blood glucose
Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed
Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed
Search for other papers by Monica R Gadelha in
Google Scholar
PubMed
levels under treatment with 20 mg were 1.06 × ULN, 120 mg/dL and 6.5%, respectively. HbA1c levels in most patients remained stable over time, and glucose fluctuations stabilised or decreased following pasireotide dose reduction. Overall, median glucose